Skip to main content
. 2019 Dec 6;55(4):453–461. doi: 10.1007/s00535-019-01652-z

Fig. 1.

Fig. 1

The risk of pancreatic cancer among long-term users of proton pump inhibitors (PPIs) (defined as ≥ 180 days accumulated use) compared to the Swedish background population, for the most common indications of use, stratified per age-group